Descrizione

Secondo StrategyHelix, the global bioinformatics market is expected to increase by US$ 9.9 miliardi durante 2022-2028, in espansione ad un CAGR di 8.1% durante il periodo di previsione.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2018-2021 e previsione a 2028 covering key market aspects like sales value for bioinformatics. The global bioinformatics market is segmented on the basis of solution, services and platforms, applicazione, end user, e regione. Based on solution, the global bioinformatics market is categorized into data analysis software and services, hardware and infrastructure, tools and database services. The tools and database services segment captured the largest share of the market in 2021. On the basis of services and platforms, the global bioinformatics market has been segmented into sequencing platforms, sequencing services. The sequencing platforms segment held the largest share of the global bioinformatics market in 2021 e si prevede che manterrà la sua quota durante il periodo di previsione. Per applicazione, the global bioinformatics market has been segmented into cheminformatics, genomics, metabolomics, pharmacogenomics, proteomics, transcriptomics, altri. In 2021, the genomics segment made up the largest share of revenue generated by the bioinformatics market. Based upon end user, the global bioinformatics market is categorized into academic institutions, agriculture, clinical and medical, altri. Tra questi, the clinical and medical segment was accounted for the highest revenue generator in 2021. Geograficamente, the global bioinformatics market is segmented into Asia Pacific, Europa, Nord America, Rest of the World (RoW).

The global bioinformatics market is highly competitive. The leading players in the bioinformatics market include Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corp., GVK Biosciences Pvt. Ltd, Illumina Inc., Ocimum Biosolutions Ltd., Thermo Fisher Scientific Inc.

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the bioinformatics market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Solution: data analysis software and services, hardware and infrastructure, tools and database services
Services and platforms: sequencing platforms, sequencing services
Applicazione: cheminformatics, genomics, metabolomics, pharmacogenomics, proteomics, transcriptomics, altri
Utente finale: academic institutions, agriculture, clinical and medical, altri
Regione: Asia Pacifico, Europa, Nord America, Rest of the World (RoW)
Anni considerati: la presente relazione copre il periodo 2018 A 2028

Principali vantaggi per gli stakeholder

– Get a comprehensive picture of the global bioinformatics market
– Individuare i settori in crescita e le tendenze per gli investimenti

Sommario

Parte 1. introduzione
– Ambito dello studio
– Periodo di studio
– Ambito geografico
– Metodologia di ricerca
Parte 2. Bioinformatics market overview
Parte 3. Market breakdown by solution
– Data analysis software and services
– Hardware and infrastructure
– Tools and database services
Parte 4. Market breakdown by services and platforms
– Sequencing platforms
– Sequencing services
Parte 5. Market breakdown by application
– Cheminformatics
– Genomics
– Metabolomics
– Pharmacogenomics
– Proteomics
– Transcriptomics
– Altri
Parte 6. Market breakdown by end user
– Academic institutions
– agricoltura
– Clinical and medical
– Altri
Parte 7. Market breakdown by region
– Asia Pacifico
– Europa
– Nord America
– Rest of the World (RoW)
Parte 8. Aziende chiave
– Agilent Technologies Inc.
– Becton, Dickinson and Company
– Bio-Rad Laboratories, Inc.
– Bio-Techne Corp.
– GVK Biosciences Pvt. Ltd
– Illumina Inc.
– Ocimum Biosolutions Ltd.
– Thermo Fisher Scientific Inc.
Informazioni su StrategyHelix
Disclaimer